Product Brochure

Introducing Levagen: Clinically studied palmitoylethanolamide for joint discomfort

Format: PDF file | Document type: Product Brochure | Promoted Content

This Product Brochure has been written by Gencor , and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

Introducing Levagen: Clinically studied palmitoylethanolamide for joint discomfort

An estimated 91.2 million adults have been medically diagnosed with some form of arthritis or symptoms related to it. With concerns about pharmaceutical side effects, consumers are looking for alternative solutions to addressing joint health.

Introducing Levagen®​ by Gencor​, an innovative PEA ingredient that utilizes the endocannabinoid system for supporting joint function, reducing joint stiffness and providing joint comfort​. Levagen is a clinically studied, self-affirmed GRAS ingredient. Usually isolated from peanuts, egg yolk and soybeans, PEA is produced in the body as a biological response and as a repair mechanism for inflammation response.

Fill out the form and download Gencor’s product brochure to learn more about Levagen and Levagen Plus™​. 

Latest content from Gencor

Related resources from Gencor

Show more

Supplier info centre